<div>In 1993 my wife Sue was diagnosed with a Pheo and as the tumours had metastasised to her bones she was given six months to live. Fortunately Sue was able to uptake a highly toxic radioactive isotope at the Beatson clinic in Glasgow Scotland. In 2002 I realised that the treatment that had kept Sue alive was taking its toll and took early retirement until Sue passed away at the end of December 2003.
</div>
<div><br />
</div>
<div>In 2010 I was informed that Sues Pheo was heritable and so I suggested to my four children that they get tested. My eldest two children do not have the faulty SDH-B gene but my twins Jennie and James had inherited the mutated gene from their mum. The rest of the immediate family were tested and Sues elder brother John who is 81 and his son Richard 42 also have the exact same faulty gene. However the faulty gene in their case has not yet become a problem. This is something I would like to learn more about.
</div>
<div><br />
</div>
<div>James was scanned and to date has had five tumours removed from his abdomen and in 2018 had a tumour successfully removed (and stored as frozen research tissue) from his neck. Sadly, he also has a tumour wrapped around his carotid artery which means surgery is impossible. Jennie has a tumour wrapped around her jugular vein which means surgery is also out of the question. Jennie also has another tumour in her neck. Unfortunately, the tumour wrapped around her jugular vein started to grow in 2014 and Jennie had to have radiotherapy. In March 2019 Jennie was told from a 2015 scan that her tumours had metastasised to her bones and she is getting monthly injections to slow the tumours growth. 
</div>
<div><br />
</div>
<div>In 2014, I was discussing the family situation with my very good friend Dr Mehta who has spent a career trying to find a cure for cystic fibrosis. In his research he realised he needed to find out how the faulty gene which causes that disease works. He told me that if we could find out how the faulty gene (SDH-B mutant) my family inherited works it may be possible to do something about it. With this in mind I went about raising funds to do basic research in Hungary with an amazing scientist Professor Krisztina Takasc who had worked with Dr Mehta on highly conserved genes that were abnormal in cystic fibrosis. The research has recently been submitted (having shown a tractable phenotype after SDHB mutation) and we continue to do research in Hungary.
</div>
<div><br />
</div>
<div>In 2018 I set up a charity in the United Kingdom called the Phaeo and Para Cancer Charity to raise funds to carry out further research.
</div>
<div><br />
</div>
<div>The work in India is being done by Dr. Aamir Nazir Principal Scientist, Division of Neuroscience and Ageing Biology Secretary, Research CouncilCSIR-Central Drug Research Institute. Dr Aamir will be Elucidating the neural role of SDHB1 in context of Paraganglioma employing a new C. elegans model.
</div>
<div><br />
</div>
<div>The work in Dundee by a start up called MicroMatrices is looking at two different tumour blocs from my son James to try to determine if there is a drug or cocktail of drugs which will help.
</div>
<div><br />
</div>
<div>We continue to push on to find answers - for those we’ve lost, those who currently fight, and the future generations to come. Thank you for all your support.
</div>

john Laidlaw

Deborah Wilson

Stevi Hogg

Anonymous

Peter A Arbuckle

Arthur Espley

Alistair Batchen

Mark Kubicki

Andrew Miller

Elizabeth Duff

Paul Daly

Tobias Mellows

Alan Boyne

Anne Hardy

Angus Tod

James Williamson

The LYCRA Company Veronique Loze

The Phaeo and Para Cancer Charity

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

The Phaeo and Para Cancer Charity

Still £51,954 to go. Help us build momentum.